CJC-1295 with Dac
$36.99
CJC-1295 with DAC is a modified analog of growth hormone–releasing hormone (GHRH) engineered with a Drug Affinity Complex (DAC) to extend its duration of activity. It has been studied in research settings for its role in growth hormone signaling pathways and endocrine regulatory mechanisms.
Usage Disclaimer: Research Use Only. This product is intended strictly for laboratory research and in-vitro studies. It is not for human or animal consumption, medical use, or diagnostic purposes. Any unauthorized use of this product is strictly prohibited.
FDA Compliance: FDA Notice. The statements made regarding these products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Research Studies
Comparative Pharmacokinetics: DAC vs Non-DAC Variants (2015)
Human | Crossover design | 30 days each arm
DAC version showed 120-hour half-life versus 30-minute half-life of non-DAC, but non-DAC preserved more physiological GH patterns.
Long-term Effects on GH/IGF-1 Axis (2012)
Animal model | 6 months | Weekly dosing
Chronic administration led to sustained IGF-1 elevation but some evidence of reduced GH pulse amplitude, suggesting partial desensitization.
Dose-Response Relationship of CJC-1295 DAC (2008)
Human | Multiple doses | 90 days | 48 subjects
Established optimal dosing at 1-2mg weekly, showing dose-dependent IGF-1 increases but also higher side effect incidence at doses above 2mg.
Pair your peptide order with bacteriostatic water for proper reconstitution and storage. Adding it now ensures you have everything you need when your order arrives.
Avoid delays and complete your setup in one shipment.
